MarketLens
Sign Up

Boston Scientific Insiders Bet on a Long-Term Rebound Amidst Near-Term Headwinds

3 months ago
SHARE THIS ON:

Boston Scientific Insiders Bet on a Long-Term Rebound Amidst Near-Term Headwinds

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Insider at Medical Device Maker Buys More Than 7,500 Shares

An insider at a medical device maker bought over 7,500 shares for $150,000, increasing his direct holdings by 14% despite the stock's 37% one-year decline.
Stock News•2 months ago

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Boston Scientific CEO Michael Mahoney bought ~200,000 shares for ~$10.0 million on August 3, 2026, at $48.34, raising his total equity holdings by 13%. The insider purchase signals management confiden...
Stock News•4 months ago

Boston Scientific: The Time Has Come To Catch This Falling Knife

Boston Scientific shares fell ~60% from a September 2025 high of $109.50 to ~$45.00, after the company cut its FY26 organic growth guidance to 6.5%-8.0% in Q1-26 earnings.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•2 hours ago

Stock Market Today, Nov. 4: Amazon Jumps 6% From New Perspective on AWS Growth and AI Strategy Following Election Results

Stock News•2 hours ago

Apple (AAPL)) Price Forecast: Record High Follows Dramatic Reversal

Stock News•2 hours ago

Apple cements its status as tech's biggest heavyweight with the stock's best day in over a year

Stock News•3 hours ago

Here's What a $1,000 Investment in AMD Could Be Worth by 2030